CoChat
Sign Up
Cited by 161

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways

El Fatimy, Rachid, Li, Shaomin, Chen, Zhicheng, Mushannen, Tasnim, Gongala, Sree, Wei, Zhiyun, Balu, Darrick T., Rabinovsky, Rosalia, Cantlon, Adam, Elkhal, Abdallah, Selkoe, Dennis J., Sonntag, Kai C., Walsh, Dominic M., Krichevsky, Anna M.·2018·Acta Neuropathologica
DOI 10.1007/s00401-018-1880-5PMC PMC6132948

Published version of a preprint

Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00401-018-1880-5

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Alkallas R, Fish L, Goodarzi H, Najafabadi HS (2017) Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer’s disease. Nat Commun 8:909. https://doi.org/10.1038/s41467-017-00867-z · DOI
  2. Bloom GS (2014) Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol 71:505–508. https://doi.org/10.1001/jamaneurol.2013.5847 · DOI
  3. Cantlon A, Frigerio CS, Freir DB, Boland B, Jin M, Walsh DM (2015) The familial British dementia mutation promotes formation of neurotoxic cystine cross-linked Amyloid Bri (ABri) oligomers. J Biol Chem 290:16502–16516. https://doi.org/10.1074/jbc.M115.652263 · DOI
  4. Chai X, Wu S, Murray TK, Kinley R, Cella CV, Sims H et al (2011) Passive immunization with anti-Tau antibodies in two transgenic models: reduction of Tau pathology and delay of disease progression. J Biol Chem 286:34457–34467. https://doi.org/10.1074/jbc.M111.229633 · DOI
  5. Chen-Plotkin AS, Unger TL, Gallagher MD, Bill E, Kwong LK, Volpicelli-Daley L et al (2012) TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J Neurosci Off J Soc Neurosci 32:11213–11227. https://doi.org/10.1523/JNEUROSCI.0521-12.2012 · DOI · Paper page
  6. Chou C-H, Shrestha S, Yang C-D, Chang N-W, Lin Y-L, Liao K-W et al (2018) miRTarBase update 2018: a resource for experimentally validated microRNA–target interactions. Nucleic Acids Res 46:D296–D302. https://doi.org/10.1093/nar/gkx1067 · DOI
  7. Chow H-M, Guo D, Zhou J-C, Zhang G-Y, Li H-F, Herrup K, Zhang J (2014) CDK5 activator protein p25 preferentially binds and activates GSK3β. Proc Natl Acad Sci USA 111:E4887–E4895. https://doi.org/10.1073/pnas.1402627111 · DOI
  8. Davis TH, Cuellar TL, Koch SM, Barker AJ, Harfe BD, McManus MT, Ullian EM (2008) Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci Off J Soc Neurosci 28:4322–4330. https://doi.org/10.1523/JNEUROSCI.4815-07.2008 · DOI · Paper page
  9. Fasulo L, Ugolini G, Visintin M, Bradbury A, Brancolini C, Verzillo V et al (2000) The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J Neurochem 75:624–633 · DOI
  10. Ferreira A, Bigio EH (2011) Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies. Mol Med Camb Mass 17:676–685. https://doi.org/10.2119/molmed.2010.00220 · DOI · Paper page
  11. Ferreira A, Lu Q, Orecchio L, Kosik KS (1997) Selective phosphorylation of adult tau isoforms in mature hippocampal neurons exposed to fibrillar A beta. Mol Cell Neurosci 9:220–234. https://doi.org/10.1006/mcne.1997.0615 · DOI · Paper page
  12. Florenzano F, Veronica C, Ciasca G, Ciotti MT, Pittaluga A, Olivero G et al (2017) Extracellular truncated tau causes early presynaptic dysfunction associated with Alzheimer’s disease and other tauopathies. Oncotarget 8:64745–64778. https://doi.org/10.18632/oncotarget.17371 · DOI
  13. Formosa A, Lena AM, Markert EK, Cortelli S, Miano R, Mauriello A et al (2013) DNA methylation silences miR-132 in prostate cancer. Oncogene 32:127–134. https://doi.org/10.1038/onc.2012.14 · DOI
  14. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL et al (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer’s disease. Proc Natl Acad Sci USA 100:10032–10037. https://doi.org/10.1073/pnas.1630428100 · DOI · Paper page
  15. Hébert SS, Wang W-X, Zhu Q, Nelson PT (2013) A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer’s disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls. J Alzheimers Dis JAD 35:335–348. https://doi.org/10.3233/JAD-122350 · DOI · Paper page
  16. Hernandez-Rapp J, Rainone S, Goupil C, Dorval V, Smith PY, Saint-Pierre M et al (2016) microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer’s disease triple transgenic mice. Sci Rep 6:30953. https://doi.org/10.1038/srep30953 · DOI
  17. Hooper C, Killick R, Lovestone S (2008) The GSK3 hypothesis of Alzheimer’s disease. J Neurochem 104:1433–1439. https://doi.org/10.1111/j.1471-4159.2007.05194.x · DOI · Paper page
  18. Hu S, Begum AN, Jones MR, Oh MS, Beech WK, Beech BH et al (2009) GSK3 inhibitors show benefits in an Alzheimer’s disease (AD) model of neurodegeneration but adverse effects in control animals. Neurobiol Dis 33:193–206. https://doi.org/10.1016/j.nbd.2008.10.007 · DOI
  19. Huppertz I, Attig J, D’Ambrogio A, Easton LE, Sibley CR, Sugimoto Y et al (2014) iCLIP: protein–RNA interactions at nucleotide resolution. Methods 65:274–287. https://doi.org/10.1016/j.ymeth.2013.10.011 · DOI
  20. Idda ML, Munk R, Abdelmohsen K, Gorospe M (2018) Noncoding RNAs in Alzheimer’s disease. Wiley Interdiscip Rev RNA. https://doi.org/10.1002/wrna.1463 · DOI
  21. Iqbal K, Liu F, Gong C-X, Grundke-Iqbal I (2010) Tau in Alzheimer disease and related tauopathies. Curr Alzheimer Res 7:656–664 · DOI
  22. Kanmert D, Cantlon A, Muratore CR, Jin M, O’Malley TT, Lee G et al (2015) C-terminally truncated forms of tau, but not full-length tau or its C-terminal fragments, are released from neurons independently of cell death. J Neurosci Off J Soc Neurosci 35:10851–10865. https://doi.org/10.1523/JNEUROSCI.0387-15.2015 · DOI
  23. Kurbatskaya K, Phillips EC, Croft CL, Dentoni G, Hughes MM, Wade MA et al (2016) Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer’s disease brain. Acta Neuropathol Commun 4:34. https://doi.org/10.1186/s40478-016-0299-2 · DOI
  24. Lau P, Bossers K, Janky R, Salta E, Frigerio CS, Barbash S et al (2013) Alteration of the microRNA network during the progression of Alzheimer’s disease. EMBO Mol Med 5:1613–1634. https://doi.org/10.1002/emmm.201201974 · DOI · Paper page
  25. Magill ST, Cambronne XA, Luikart BW, Lioy DT, Leighton BH et al (2010) microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus. Proc Natl Acad Sci USA 107:20382–20387. https://doi.org/10.1073/pnas.1015691107 · DOI · Paper page
  26. Majer A, Medina SJ, Niu Y, Abrenica B, Manguiat KJ, Frost KL et al (2012) Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog 8:e1003002. https://doi.org/10.1371/journal.ppat.1003002 · DOI
  27. Marler KJ, Suetterlin P, Dopplapudi A, Rubikaite A, Adnan J, Maiorano NA et al (2014) BDNF promotes axon branching of retinal ganglion cells via miRNA-132 and p250GAP. J Neurosci Off J Soc Neurosci 34:969–979. https://doi.org/10.1523/JNEUROSCI.1910-13.2014 · DOI
  28. Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J et al (2013) Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron 79:1094–1108. https://doi.org/10.1016/j.neuron.2013.07.037 · DOI · Paper page
  29. Mellios N, Sugihara H, Castro J, Banerjee A, Le C, Kumar A et al (2011) miR-132, an experience-dependent microRNA, is essential for visual cortex plasticity. Nat Neurosci 14:1240–1242. https://doi.org/10.1038/nn.2909 · DOI · Paper page
  30. Minogue AM, Stubbs AK, Frigerio CS, Boland B, Fadeeva JV, Tang J et al (2009) Gamma-secretase processing of APLP1 leads to the production of a p3-like peptide that does not aggregate and is not toxic to neurons. Brain Res 1262:89–99. https://doi.org/10.1016/j.brainres.2009.01.008 · DOI
  31. Modi PK, Jaiswal S, Sharma P (2016) Regulation of neuronal cell cycle and apoptosis by MicroRNA 34a. Mol Cell Biol 36:84–94. https://doi.org/10.1128/MCB.00589-15 · DOI
  32. Olde Loohuis NFM, Kos A, Martens GJM, Van Bokhoven H, Nadif Kasri N, Aschrafi A (2012) MicroRNA networks direct neuronal development and plasticity. Cell Mol Life Sci CMLS 69:89–102. https://doi.org/10.1007/s00018-011-0788-1 · DOI
  33. Ottesen EW (2017) ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy. Transl Neurosci 8:1–6. https://doi.org/10.1515/tnsci-2017-0001 · DOI
  34. Park S-Y, Ferreira A (2005) The generation of a 17 kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci Off J Soc Neurosci 25:5365–5375. https://doi.org/10.1523/JNEUROSCI.1125-05.2005 · DOI · Paper page
  35. Patrick E, Rajagopal S, Wong H-KA, McCabe C, Xu J, Tang A et al (2017) Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer’s disease. Mol Neurodegener 12:51. https://doi.org/10.1186/s13024-017-0191-y · DOI · Paper page
  36. Pichler S, Gu W, Hartl D, Gasparoni G, Leidinger P, Keller A et al (2017) The miRNome of Alzheimer’s disease: consistent downregulation of the miR-132/212 cluster. Neurobiol Aging 50:167.e1–167.e10. https://doi.org/10.1016/j.neurobiolaging.2016.09.019 · DOI · Paper page
  37. Pooler AM, Phillips EC, Lau DHW, Noble W, Hanger DP (2013) Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep 14:389–394. https://doi.org/10.1038/embor.2013.15 · DOI · Paper page
  38. Rao MV, McBrayer MK, Campbell J, Kumar A, Hashim A, Sershen H et al (2014) Specific calpain inhibition by calpastatin prevents tauopathy and neurodegeneration and restores normal lifespan in tau P301L mice. J Neurosci Off J Soc Neurosci 34:9222–9234. https://doi.org/10.1523/JNEUROSCI.1132-14.2014 · DOI
  39. Rapoport M, Dawson HN, Binder LI, Vitek MP, Ferreira A (2002) Tau is essential to beta-amyloid-induced neurotoxicity. Proc Natl Acad Sci USA 99:6364–6369. https://doi.org/10.1073/pnas.092136199 · DOI · Paper page
  40. Reinecke JB, DeVos SL, McGrath JP, Shepard AM, Goncharoff DK, Tait DN et al (2011) Implicating calpain in tau-mediated toxicity in vivo. PLoS One 6:e23865. https://doi.org/10.1371/journal.pone.0023865 · DOI
  41. Salta E, De Strooper B (2017) microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer’s disease. FASEB J 31(2):424–433. https://doi.org/10.1096/fj.201601308 · DOI · Paper page
  42. Salta E, Sierksma A, Vanden Eynden E, De Strooper B (2016) miR-132 loss de-represses ITPKB and aggravates amyloid and TAU pathology in Alzheimer’s brain. EMBO Mol Med 8:1005–1018. https://doi.org/10.15252/emmm.201606520 · DOI · Paper page
  43. Schaefer A, O’Carroll D, Tan CL, Hillman D, Sugimori M, Llinas R, Greengard P (2007) Cerebellar neurodegeneration in the absence of microRNAs. J Exp Med 204:1553–1558. https://doi.org/10.1084/jem.20070823 · DOI · Paper page
  44. Smith PY, Delay C, Girard J, Papon M-A, Planel E, Sergeant N et al (2011) MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy. Hum Mol Genet 20:4016–4024. https://doi.org/10.1093/hmg/ddr330 · DOI · Paper page
  45. Smith PY, Hernandez-Rapp J, Jolivette F, Lecours C, Bisht K, Goupil C et al (2015) miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo. Hum Mol Genet 24:6721–6735. https://doi.org/10.1093/hmg/ddv377 · DOI · Paper page
  46. van Spronsen M, van Battum EY, Kuijpers M, Vangoor VR, Rietman ML, Pothof J et al (2013) Developmental and activity-dependent miRNA expression profiling in primary hippocampal neuron cultures. PLoS One 8:e74907. https://doi.org/10.1371/journal.pone.0074907 · DOI · Paper page
  47. Takashima A, Noguchi K, Sato K, Hoshino T, Imahori K (1993) Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc Natl Acad Sci USA 90:7789–7793 · DOI
  48. Valor LM, Viosca J, Lopez-Atalaya JP, Barco A (2013) Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. Curr Pharm Des 19:5051–5064 · DOI
  49. Walsh DM, Thulin E, Minogue AM, Gustavsson N, Pang E, Teplow DB, Linse S (2009) A facile method for expression and purification of the Alzheimer’s disease-associated amyloid beta-peptide. FEBS J 276:1266–1281. https://doi.org/10.1111/j.1742-4658.2008.06862.x · DOI
  50. Wanet A, Tacheny A, Arnould T, Renard P (2012) miR-212/132 expression and functions: within and beyond the neuronal compartment. Nucleic Acids Res 40:4742–4753. https://doi.org/10.1093/nar/gks151 · DOI
  51. Wang Y, Veremeyko T, Wong AH-K, El Fatimy R, Wei Z, Cai W, Krichevsky AM (2017) Downregulation of miR-132/212 impairs S-nitrosylation balance and induces tau phosphorylation in Alzheimer’s disease. Neurobiol Aging 51:156–166. https://doi.org/10.1016/j.neurobiolaging.2016.12.015 · DOI · Paper page
  52. Wayman GA, Davare M, Ando H, Fortin D, Varlamova O, Cheng H-YM et al (2008) An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP. Proc Natl Acad Sci USA 105:9093–9098. https://doi.org/10.1073/pnas.0803072105 · DOI · Paper page
  53. Wei Z, Batagov AO, Schinelli S, Wang J, Wang Y, EL Fatimy R et al (2017) Coding and noncoding landscape of extracellular RNA released by human glioma stem cells. Nat Commun 8:1145. https://doi.org/10.1038/s41467-017-01196-x · DOI
  54. Wong H-KA, Veremeyko T, Patel N, Lemere CA, Walsh DM, Esau C et al (2013) De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer’s disease. Hum Mol Genet 22:3077–3092. https://doi.org/10.1093/hmg/ddt164 · DOI · Paper page
  55. Zhao X, Kotilinek LA, Smith B, Hlynialuk C, Zahs K, Ramsden M et al (2016) Caspase-2 cleavage of tau reversibly impairs memory. Nat Med 22:1268–1276. https://doi.org/10.1038/nm.4199 · DOI · Paper page

Cited by

Sorted by citations

Metadata

Authors
El Fatimy, R., Li, S., Chen, Z., Mushannen, T., Gongala, S., Wei, Z., Balu, D. T., Rabinovsky, R., Cantlon, A., Elkhal, A., Selkoe, D. J., Sonntag, K. C., Walsh, D. M., & Krichevsky, A. M.
Venue
Acta Neuropathologica
Publisher
Springer Science and Business Media LLC
Published
2018-07-07
Volume
136
Issue
4
Pages
537-555
ISSN
  • 0001-6322
  • 1432-0533
DOI
10.1007/s00401-018-1880-5
PMC
PMC6132948
Cited by
161
References
17
Language
en
Licence
creativecommons.org/licenses/by/4.0 (tdm)
Funders
  • Alzheimer's Association (NIRG-09-132844)
  • Rainwater Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review